Viaskin® Peanut (DBV712) Expanded Access Protocol

Safety, Efficacy and Pharmacokinetic Study of Teduglutide in Infants 4 to 12 Months of Age With Short Bowel Syndrome

NCT03571516 ·Status: COMPLETED ·Phase: PHASE3

Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome

NCT01495793 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)

NCT00172185 ·Status: COMPLETED ·Phase: PHASE3

PEAnut Anaphylaxis Predictors

NCT02424136 ·Status: COMPLETED ·Phase: NA

Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome

NCT03649477 ·Status: COMPLETED ·Phase: PHASE3

Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition

NCT02682381 ·Status: COMPLETED ·Phase: PHASE3

Intravenous Immunoglobulin (IVIG) Versus Plasma Exchange (PE) for Ventilated Children With Guillain Barre Syndrome (GBS)

NCT01306578 ·Status: COMPLETED ·Phase: NA

Safety and Efficacy Study of Acthar in Subjects With ARDS

NCT02113735 ·Status: WITHDRAWN ·Phase: PHASE2

Study of Subcutaneous Rehydration With Recombinant Human Hyaluronidase for Infants and Children

NCT00477152 ·Status: COMPLETED ·Phase: PHASE4

Using Commonly Available Food Products To Treat Food Allergy

NCT05503446 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

A Study of LJPC-501 in Paediatric Patients With Hypotension Associated With Distributive or Vasodilatory Shock

NCT03623529 ·Status: UNKNOWN ·Phase: PHASE2

A Study of the Safety, Efficacy and Pharmacokinetics of Glycerol Phenylbutyrate in Pediatric Subjects Under 2 Years of Age With Urea Cycle Disorders

NCT02246218 ·Status: COMPLETED ·Phase: PHASE4

Safety During Use of Paediatric Triple Chamber Bag Formulas

NCT01304394 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome

NCT00081458 ·Status: COMPLETED ·Phase: PHASE3

Study of the Safety and Tolerability of HPN-100 Compared to Sodium Phenylbutyrate in Children With Urea Cycle Disorders

NCT00947544 ·Status: COMPLETED ·Phase: PHASE2

Intravenous Heparin as an Adjunct for the Treatment of Anaphylactic Reactions in an Emergency Department

NCT00657228 ·Status: WITHDRAWN ·Phase: NA

A Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome

NCT01952080 ·Status: COMPLETED ·Phase: PHASE3

Glutamine for the Prophylaxis of Vincristine-induced Neuropathy in Children and Adolescents With Cancer.

NCT07287592 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

TubeClear® Evaluation in Pediatric Patients (Phase I)

NCT02724631 ·Status: TERMINATED ·Phase: NA

Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616) for Reversal of Neuromuscular Blockade in Pediatric Participants Aged Birth to <2 Years (MK-8616-169)

NCT03909165 ·Status: COMPLETED ·Phase: PHASE4

Evaluation of 70% Ethanol Lock Solution to Prevent Catheter Related Blood Stream Infections in Pediatric Patients

NCT01409772 ·Status: WITHDRAWN

Intranasal Fentanyl Versus Placebo for Catheterization During a Voiding Cystourethrogram in Children

NCT00405444 ·Status: COMPLETED ·Phase: PHASE3

Transurethral Myoblast Injection for Urinary Incontinence in Children With Bladder Exstrophy

NCT02075216 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Methoxsalen and Extracorporeal Photopheresis (ECP) for the Treatment of Pediatric Participants With Steroid Refractory Acute Graft Versus Host Disease

NCT02524847 ·Status: TERMINATED ·Phase: PHASE3

Sodium Citrate 4% Locking Solution for Children Requiring Home Parenteral Nutrition

NCT04756427 ·Status: TERMINATED ·Phase: PHASE4